These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 29132428

  • 21. Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25.
    Mlambo G, Maciel J, Kumar N.
    Infect Immun; 2008 May; 76(5):2018-24. PubMed ID: 18316385
    [Abstract] [Full Text] [Related]

  • 22. Characterization of a Sulfhydryl Oxidase From Plasmodium berghei as a Target for Blocking Parasite Transmission.
    Zheng W, Liu F, Du F, Yang F, Kou X, He Y, Feng H, Fan Q, Luo E, Min H, Miao J, Cui L, Cao Y.
    Front Cell Infect Microbiol; 2020 May; 10():311. PubMed ID: 32670896
    [Abstract] [Full Text] [Related]

  • 23. Expression of the Plasmodium berghei ookinete protein Pbs21 in a baculovirus-insect cell system produces an efficient transmission blocking immunogen.
    Margos G, Kurtenbach K, Posnett E, Barker GC, Matsuoka H, Paton MG, Sinden RE.
    Parasite Immunol; 1995 Apr; 17(4):167-76. PubMed ID: 7624157
    [Abstract] [Full Text] [Related]

  • 24. Essential role of GEXP15, a specific Protein Phosphatase type 1 partner, in Plasmodium berghei in asexual erythrocytic proliferation and transmission.
    Hollin T, De Witte C, Fréville A, Guerrera IC, Chhuon C, Saliou JM, Herbert F, Pierrot C, Khalife J.
    PLoS Pathog; 2019 Jul; 15(7):e1007973. PubMed ID: 31348803
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.
    Mizutani M, Iyori M, Blagborough AM, Fukumoto S, Funatsu T, Sinden RE, Yoshida S.
    Infect Immun; 2014 Oct; 82(10):4348-57. PubMed ID: 25092912
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate.
    Jaijyan DK, Singh H, Singh AP.
    J Biol Chem; 2015 Aug 07; 290(32):19496-511. PubMed ID: 25960542
    [Abstract] [Full Text] [Related]

  • 30. The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.
    Ramjanee S, Robertson JS, Franke-Fayard B, Sinha R, Waters AP, Janse CJ, Wu Y, Blagborough AM, Saul A, Sinden RE.
    Vaccine; 2007 Jan 15; 25(5):886-94. PubMed ID: 17049690
    [Abstract] [Full Text] [Related]

  • 31. A G-Protein-Coupled Receptor Modulates Gametogenesis via PKG-Mediated Signaling Cascade in Plasmodium berghei.
    Wang PP, Jiang X, Zhu L, Zhou D, Hong M, He L, Chen L, Yao S, Zhao Y, Chen G, Wang C, Cui L, Cao Y, Zhu X.
    Microbiol Spectr; 2022 Apr 27; 10(2):e0015022. PubMed ID: 35404079
    [Abstract] [Full Text] [Related]

  • 32. Translational repression of the cpw-wpc gene family in the malaria parasite Plasmodium.
    Rao PN, Santos JM, Pain A, Templeton TJ, Mair GR.
    Parasitol Int; 2016 Oct 27; 65(5 Pt A):463-71. PubMed ID: 27312996
    [Abstract] [Full Text] [Related]

  • 33. PSOP1, putative secreted ookinete protein 1, is localized to the micronemes of Plasmodium yoelii and P. berghei ookinetes.
    Tachibana M, Iriko H, Baba M, Torii M, Ishino T.
    Parasitol Int; 2021 Oct 27; 84():102407. PubMed ID: 34147682
    [Abstract] [Full Text] [Related]

  • 34. Induction of anti-malarial transmission blocking immunity with a recombinant ookinete surface antigen of Plasmodium berghei produced in silkworm larvae using the baculovirus expression vector system.
    Matsuoka H, Kobayashi J, Barker GC, Miura K, Chinzei Y, Miyajima S, Ishii A, Sinden RE.
    Vaccine; 1996 Feb 27; 14(2):120-6. PubMed ID: 8852407
    [Abstract] [Full Text] [Related]

  • 35. Plasmodium berghei merozoite surface protein-9: immunogenicity and protective efficacy using a homologous challenge model.
    Lopera-Mesa TM, Kushwaha A, Mohmmed A, Chauhan VS.
    Vaccine; 2008 Mar 04; 26(10):1335-43. PubMed ID: 18272263
    [Abstract] [Full Text] [Related]

  • 36. Plasmodium berghei XAT: protective 155/160 kDa antigens are located in parasitophorous vacuoles of schizont-stage parasite.
    Kobayashi F, Waki S, Niikura M, Tachibana M, Tsuboi T, Torii M, Kamiya S.
    Exp Parasitol; 2007 Aug 04; 116(4):450-7. PubMed ID: 17442306
    [Abstract] [Full Text] [Related]

  • 37. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.
    Dutta S, Tewari A, Balaji C, Verma R, Moitra A, Yadav M, Agrawal P, Sahal D, Jarori GK.
    Malar J; 2018 Aug 20; 17(1):304. PubMed ID: 30126436
    [Abstract] [Full Text] [Related]

  • 38. Plasmodium transmission blocking activities of Vernonia amygdalina extracts and isolated compounds.
    Abay SM, Lucantoni L, Dahiya N, Dori G, Dembo EG, Esposito F, Lupidi G, Ogboi S, Ouédraogo RK, Sinisi A, Taglialatela-Scafati O, Yerbanga RS, Bramucci M, Quassinti L, Ouédraogo JB, Christophides G, Habluetzel A.
    Malar J; 2015 Jul 25; 14():288. PubMed ID: 26208861
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.